术前负荷剂量rhBNP对急性前壁心肌梗死行急诊经皮冠状动脉介入时冠脉无复流的干预作用

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (488 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the effect of bolus intravenous injection of recombinant human brain natriuretic peptide (rhBNP) before primary percutaneous coronary intervention (PCI) on coronary no-reflow in patients with anterior wall acute myocardial infarction (AMI).Methods Eighty consecutive patients with anterior wall AMI after Primary PCI were randomly divided into therapy group(n=40) and control group(n=40). Patients in therapy group were treated with bolus intravenous injection of rhBNP (1.5 μg/kg). Both the control and the therapy group received conventional treatment. The neuroendocrine hormone level, inflammatory factor level and ventricular function were measured upon admission and 7 days later. The incidence of coronary no-reflow in both groups was observed during PCI.Results The incidence of coronary no-reflow and reperfusion arrhythmia in therapy group markedly decreased compared with control group (P＜0.05). No adverse events during drug infusion were observed and MACE during hospitalization was also similar in both groups.Conclusions Patients with anterior wall AMI before primary PCI treated with bolus intravenous injection of rhBNP can markedly decrease the coronary no-reflow and reperfusion arrhythmia.

Key words： recombinant human brain natriuretic peptide percutaneous coronary intervention anterior wall acute myocardial infarction no-reflow

Received: 05 January 2017

ZTFLH:

R542.22

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	SONG Donglin
	LI Chunhua
	and YANG Tao

Cite this article:

SONG Donglin,LI Chunhua,and YANG Tao. Effects of bolus intravenous injection of rhBNP before primary PCI on coronary no-reflow in patients with anterior wall acute myocardial infarction[J]. Med. J. Chin. Peop. Armed Poli. Forc., 2017, 28(5): 437-439.

URL:

http://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR http://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2017/V28/I5/437

[1]	Fox KA,Steg PG,Eagle KA, et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006[J]. Jama, 2007, 297 (17): 1892-1900.
[2]	刘庆. 尿酸对急性心肌梗死急诊PCI术后患者近期预后的影响[J]. 武警医学, 2016,27(10):990-993.
[3]	杨国红,王伟.AMI患者急诊PCI术后无复流现象的相关因素及近期预后[J]. 天津医科大学学报,2008,14(4):568-570.
[4]	Li J W,Chen Y D,Chen W R, et al. Plasma DPP4 activity is associated with no-reflow and major bleeding events in Chinese PCI-treated STEMI patients[J]. Scientific reports, 2016, 6:39412.
[5]	Arslan U,Yaman M,Kocaoglu I, et al. Risk of no-reflow in culprit lesion versus culprit vessel PCI in acute STEMI[J]. Coronary Artery Disease, 2015,26(6):510-515.
[6]	罗建平,刘惠亮. 维拉帕米治疗急性心肌梗死直接经皮冠状动脉介入术中无复流疗效的观察[J]. 武警医学, 2008, 19 (5): 441-444.
[7]	Wang S,Qu X,Qu Y, et al. The effect of B-type brain natriuretic peptide on patients with acute decompensated heart failure coexisting with lung cancer: a randomized controlled clinical trial[J]. Die Pharmazie, 2014, 69 (3): 212-216.
[8]	Naffaa M,Makhoul B F,Tobia A, et al. Brain natriuretic peptide at discharge as a predictor of 6-month mortality in acute decompensated heart failure[J]. Am J Emer Med, 2014, 32 (1): 44-49.
[9]	付尧,白子清. 重组脑利钠肽治疗慢性心力衰竭对醛固酮及内皮素-1的影响[J]. 中国循环杂志, 2007, 22 (1): 18-21.
[10]	Kasama S,Furuya M,Toyama T, et al. Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction[J]. Euro heart J, 2008,29(12):1485-1494.